🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a two-period, double-blind study in healthy adult female subj...
Status
Terminated
Location
GSK Investigational Site
Start Date
2010-09-14
Trial ID
NCT01195974
Treatments Being Tested
In this study, approximately 16 subjects will receive raltegravir 400mg twi...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-04
Trial ID
NCT01101893
Treatments Being Tested
This 48 week, phase 2b study in 150 HIV-1 infected antiretroviral therapy e...
Status
Terminated
Location
GSK Investigational Site
Start Date
2010-10-05
Trial ID
NCT01199731
Treatments Being Tested
This is a single-center, randomized, two part, open-label, crossover study ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-09
Trial ID
NCT01209117
This 96 week, Phase 2b study in 150 HIV-1 infected antiretroviral (ART) nai...
Status
Terminated
Location
GSK Investigational Site
Start Date
2010-11-18
Trial ID
NCT01231555
Treatments Being Tested
This is a single-center, randomized, two part, open-label, crossover study ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-12-21
Trial ID
NCT01031472
GSK has in-licensed a novel NNRTI-class candidate (GSK2248761, IDX12899) fo...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-20
Trial ID
NCT00945282
Treatments Being Tested
This study is a Phase I, open-label, single-sequence drug interaction study...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06
Trial ID
NCT01138072
Treatments Being Tested
This is a single-center, open-label, three-period, fixed-sequence cross ove...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2011-03
Trial ID
NCT01283100
Treatments Being Tested
This study is a Phase I, open-label, single dose, mass balance study in a c...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2011-01
Trial ID
NCT01273103
Treatments Being Tested